NO173506C - Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler - Google Patents

Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler

Info

Publication number
NO173506C
NO173506C NO884834A NO884834A NO173506C NO 173506 C NO173506 C NO 173506C NO 884834 A NO884834 A NO 884834A NO 884834 A NO884834 A NO 884834A NO 173506 C NO173506 C NO 173506C
Authority
NO
Norway
Prior art keywords
disulfur
analogs
preparing
procedure
tumor agents
Prior art date
Application number
NO884834A
Other languages
English (en)
Norwegian (no)
Other versions
NO884834L (no
NO173506B (no
NO884834D0 (no
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO884834D0 publication Critical patent/NO884834D0/no
Publication of NO884834L publication Critical patent/NO884834L/no
Publication of NO173506B publication Critical patent/NO173506B/no
Publication of NO173506C publication Critical patent/NO173506C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO884834A 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler NO173506C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (4)

Publication Number Publication Date
NO884834D0 NO884834D0 (no) 1988-10-28
NO884834L NO884834L (no) 1989-05-02
NO173506B NO173506B (no) 1993-09-13
NO173506C true NO173506C (no) 1993-12-22

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884833A NO176480C (no) 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler
NO884834A NO173506C (no) 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884833A NO176480C (no) 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler

Country Status (19)

Country Link
EP (2) EP0313873B1 (fr)
JP (2) JP2720933B2 (fr)
KR (2) KR0133130B1 (fr)
AR (1) AR246083A1 (fr)
AT (2) ATE112172T1 (fr)
AU (2) AU618763B2 (fr)
BR (1) BR1100939A (fr)
CA (1) CA1321582C (fr)
DE (2) DE3889063T2 (fr)
DK (2) DK174739B1 (fr)
ES (2) ES2061586T3 (fr)
FI (2) FI91262C (fr)
HK (2) HK131997A (fr)
IE (2) IE65053B1 (fr)
IL (2) IL87946A (fr)
NO (2) NO176480C (fr)
NZ (2) NZ226726A (fr)
PT (2) PT88882B (fr)
ZA (2) ZA888127B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
ATE338120T2 (de) 1998-11-27 2006-09-15 Ucb Sa Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
US7381409B2 (en) 2003-06-16 2008-06-03 Celltech R&D, Inc. Antibodies specific for sclerostin and methods of screening and use therefor
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
CN105683159B (zh) * 2013-11-04 2017-12-19 辉瑞大药厂 用于合成加利车霉素衍生物的中间体和方法
MX2019008773A (es) * 2017-01-24 2019-09-18 Pfizer Derivados de caliqueamicina y conjugados anticuerpo-farmaco de los mismos.
KR20210118945A (ko) * 2019-02-15 2021-10-01 유니버시티 오브 써던 캘리포니아 Lym-1 및 lym-2 항체 조성물 및 개선된 car 구성물
JPWO2022085762A1 (fr) * 2020-10-22 2022-04-28

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
EP0040506B1 (fr) * 1980-05-21 1986-08-20 Teijin Limited Polymère réactif et procédé pour sa préparation
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (fr) * 1984-05-23 1993-03-09 Franz Jansen Methode de preparation de conjugues formes d'un ionophore carboxylique monovalent associe par une liaison de covalence a une macromolecule et utiles comme agents de potentialisation d'immunotoxines
EP0182152B1 (fr) * 1984-11-16 1999-05-26 American Cyanamid Company Antibiotiques antitumoraux (complexe LL-E33288)
EP0330874A3 (fr) * 1988-02-29 1989-10-18 American Cyanamid Company Agents antibactériens et antitumoraux LL-E33288 epsilon-I et LL-E33288-epsilon-Br, avec les procédés et intermédiaires pour obtention desdits agents
EP0342341A3 (fr) * 1988-05-17 1991-07-24 American Cyanamid Company Méthode pour la fabrication de l'antibiotique antitumoral LL-E33288 Gamma 2

Also Published As

Publication number Publication date
JPH0296599A (ja) 1990-04-09
IL87947A (en) 1995-05-26
EP0313874A3 (en) 1990-05-09
FI884984A (fi) 1989-05-01
FI91262C (fi) 1994-06-10
ZA888127B (en) 1989-07-26
HK131897A (en) 1997-10-03
AU2448988A (en) 1989-05-04
IE883261L (en) 1989-04-30
JP2820256B2 (ja) 1998-11-05
ZA888123B (en) 1989-07-26
IL87946A0 (en) 1989-03-31
EP0313873B1 (fr) 1994-09-28
FI884983A0 (fi) 1988-10-28
CA1321582C (fr) 1993-08-24
AR246083A1 (es) 1994-03-30
DE3889063D1 (de) 1994-05-19
NZ226727A (en) 1991-12-23
ATE112172T1 (de) 1994-10-15
ATE104309T1 (de) 1994-04-15
PT88881B (pt) 1993-01-29
AU618763B2 (en) 1992-01-09
BR1100939A (pt) 1999-08-31
AU612714B2 (en) 1991-07-18
FI884983A (fi) 1989-05-01
ES2061586T3 (es) 1994-12-16
HK131997A (en) 1997-10-03
IL87946A (en) 1995-06-29
FI95204C (fi) 1996-01-10
FI95204B (fi) 1995-09-29
KR0133130B1 (ko) 1998-04-17
EP0313874B1 (fr) 1994-04-13
DK602588D0 (da) 1988-10-28
DK602488A (da) 1989-05-01
DE3889063T2 (de) 1994-12-01
NO884834L (no) 1989-05-02
FI91262B (fi) 1994-02-28
JPH01193282A (ja) 1989-08-03
NO884833L (no) 1989-05-02
NO173506B (no) 1993-09-13
IE883262L (en) 1989-04-30
AU2449488A (en) 1989-05-04
DK602588A (da) 1989-05-01
NO176480C (no) 1995-04-12
FI884984A0 (fi) 1988-10-28
NZ226726A (en) 1991-08-27
NO884834D0 (no) 1988-10-28
EP0313874A2 (fr) 1989-05-03
KR970011385B1 (ko) 1997-07-10
PT88882B (pt) 1993-01-29
IE65053B1 (en) 1995-10-04
KR890006244A (ko) 1989-06-12
DK174739B1 (da) 2003-10-13
KR890006245A (ko) 1989-06-12
DK602488D0 (da) 1988-10-28
ES2059464T3 (es) 1994-11-16
IL87947A0 (en) 1989-03-31
IE65989B1 (en) 1995-11-29
NO176480B (no) 1995-01-02
DE3851682T2 (de) 1995-05-04
EP0313873A1 (fr) 1989-05-03
NO884833D0 (no) 1988-10-28
JP2720933B2 (ja) 1998-03-04
DE3851682D1 (de) 1994-11-03

Similar Documents

Publication Publication Date Title
PT86875A (pt) Process for the preparation of phenylcarbamate
NO171167C (no) Analogifremgangsmaate ved fremstilling av cytidin-derivater
NO171556C (no) Fremgangsmaate for fremstilling av azitromycin dihydrat
FI88998B (fi) Foerfarande och anordning foer framstaellning av ett aromaemne med koettsmak
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
NO173506C (no) Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler
PT87191A (pt) Process for the preparation of nucleosides
NO173732C (no) Analogifremgangsmaate for fremstilling av 2-arylsubstituerte N- acetyltryptaminer
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
PT87698A (pt) Procede de preparation de derives de n-phenylpyrazole
FI881064A0 (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
NO874194D0 (no) Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO172351C (no) Fremgangsmaate for fremstilling av glykopeptider
PT87687A (pt) Process for the preparation of 9 (11)-dihydro steroids
TR23355A (tr) Naftasen'lerin hazirlanmasi icin usul
PT87643A (pt) Process for the preparation of pyran compounds
IT1223485B (it) Procedimento per la preparazione di componenti ceramici
IT1223408B (it) Procedimento per la preparazione di monosialoganglioside
PT86899A (pt) Process for preparing 27-halo derivatives of ll-f28249 compounds
PT87732A (pt) Process for the preparation of (e)-(p-fluorophenethyl)-3-fluoroallylamine
NO840433L (no) Fremgangsmaate ved fremstilling av mitomicinanaloger
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
PT88465A (pt) Process for the preparation of macrolide compounds
PT88467A (pt) Process for the preparation of macrolide compounds

Legal Events

Date Code Title Description
MK1K Patent expired